Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01891682 · ClinicalTrials.gov registry record

Methionine Metabolism in Parenterally Fed Pediatric Sepsis

A clinical trial, sponsored by The Cleveland Clinic.

Completed
Registry status
45
Enrollment target

NCT01891682: Completed study, sponsored by The Cleveland Clinic.

NCT01891682 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01891682 has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
45 participants
Enrollment target

Study Summary

Critically ill children have abnormal utilization of nutrients such as glucose, lipids and protein. Protein synthesis is increased mainly in the form of immune and signaling proteins, while synthesis of muscle and structural proteins is decreased. The metabolism of sulfur amino acids and specifically methionine and cysteine have not been investigated in critically ill septic children, despite that sulfur amino acids have important roles on thiol, antioxidant and epigenetic reactions, as well as precursor of glutathione (GSH). Methionine metabolism in critically ill children will be influenced by its rate of utilization through the transmethylation, remethylation and transsulfuration pathways, which are the major pathways of methionine metabolism. The investigators study aims to investigate the metabolism of methionine and cysteine in parenterally fed critically ill septic children. The investigators aim to determine the rates of transmethylation, remethylation, transsulfuration and GSH synthesis rates in critically ill septic children, to determine in vivo, whole body sulfur amino acid metabolism when sulfur amino acids are supplied by the parenteral route. The objective is to determine whether current parenteral intakes support GSH synthesis and if methionine metabolism differs when supplied by the parenteral versus the enteral route. Methionine parenteral requirements will be also studied by using the indicator amino acid oxidation and balance technique.

Primary Outcome

Breakpoint between the rates of indicator amino acid oxidation and level of parenteral methionine intake.

Interventions

  • OTHER Observational

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2012-10
Est. Completion 2016-10
The Cleveland Clinic

688 total trials

What the finished NCT01891682 record still lists

NCT01891682 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.

NCT01891682 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01891682 about?

NCT01891682 is a clinical study titled "Methionine Metabolism in Parenterally Fed Pediatric Sepsis". Critically ill children have abnormal utilization of nutrients such as glucose, lipids and protein. Protein synthesis is increased mainly in the form of immune and signaling proteins, while synthesis of muscle and structural proteins is decreased. The metabolism of sulfur amino acids and specificall...

What is the current status of trial NCT01891682?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2012-10. Estimated completion is 2016-10.

What interventions are being tested in trial NCT01891682?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT01891682?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01891682, the US trial registry maintained by the National Library of Medicine. NCT01891682 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.